Jan 1, 2025 · Non-Oncology. As a marker of activated fibroblasts, FAP is a promising biomarker for a range of inflammatory and fibrosing diseases. Preliminary studies in small cohorts of …

Jan 1, 2025 · Prostate-specific membrane antigen (PSMA) PET was approved by the U.S. Food and Drug Administration in 2020 for the staging of newly diagnosed prostate cancer, yet rates …

May 1, 2008 · 2224 Objectives: Evaluation of cardiac nuclear stress test and cardiac CT. Methods: Cardiac stress imaging is an accurate procedure in detecting physiological l disease …

May 1, 2017 · 1138 Objectives: To identify the presence of shunting in patients with either cardiac or systemic right to left shunting. Methods: Patients were injected with 4 millicuries of …

241632 Introduction: Lu-177 PSMA (Pluvicto) radioligand therapy received FDA approval on March 23, 2022, for the treatment of patients with PSMA-positive metastatic castrate resistant …

EDITOR'S PAGE More Unacceptable Denials: Now It’s PSMA-Targeted PET/CT Imaging Johannes Czernin1, Thaiza Adams1, and Jeremie Calais2 1David Geffen School of Medicine …

Nuclear Medicine in Clinical Diagnosis and Treatment P.J. Ell and S.S. Gambhir New York, NY: Churchill Livingstone, 2004, 1,924 pages, $399 This third edition is dedicated to Professor …

May 1, 2020 · 3048 Objectives: Since our facility started performing DaTscan procedures in December 2017, Siemens Esoft workstations have been utilized to visually read the images. …

RADIONUCLIDE THERAPY 91 Localized In Vivo Prodrug Activation Using Radionuclides JeremyM.Quintana,FangchaoJiang,MikyungKang, VictorValladolidOnecha,ArdaK€onik ...

Jan 1, 2025 · PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received 177 Lu-PSMA-617: …